Recombinant IL13 (Cendakimab Biosimilar) antibody
This Humanized Chimeric antibody specifically detects IL13 (Cendakimab Biosimilar) . It exhibits reactivity toward Human.
Catalog No. ABIN7597584
-15% Promotion 2026
$340.97
save $60.17 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 14 Business Days
Quick Overview for Recombinant IL13 (Cendakimab Biosimilar) antibody (ABIN7597584)
Target
IL13 (Cendakimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This IL13 (Cendakimab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Cendakimab Biosimilar Antibody
-
Specificity
- IL13, NC30, Interleukin-13, IL-13
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 5.25 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- IL13 (Cendakimab Biosimilar)
-
Alternative Name
- Cendakimab Biosimilar
-
Target Type
- Biosimilar
-
Background
- IL13, NC30, Interleukin-13, IL-13
-
UniProt
- P35225
-
CAS-No
- 2151032-62-9
Target
-
You are here:
